Kymera Therapeutics, Inc. (KYMR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Company Overview - Kymera Therapeutics is a leader in the targeted protein degradation field, approaching its 10-year anniversary since founding in May [2] - The company has evolved significantly in terms of capabilities and pipeline development [2] Focus Area - Kymera has narrowed its focus to the immunology space, identifying substantial opportunities to develop drugs that leverage targeted protein degradation [3] - The company aims to achieve biologic-like efficacy while maintaining a safety profile comparable to existing biologic drugs [3]